| Product Code: ETC070072 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Cambodia Biobanking Market was estimated at USD 1459 Million in 2025 and is projected to reach USD 2073 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This growth trajectory is fueled by an increasing focus on healthcare advancements, including personalized medicine and precision healthcare. As research capabilities expand and healthcare infrastructure improves, the demand for high-quality biological samples for medical research and diagnostics will continue to rise.
This graph highlights how the Cambodia Biobanking Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 5.8% | Expansion of commercial construction activities |
| 2022 | 6.0% | Increasing adoption of advanced technologies |
| 2023 | 6.3% | Increasing industrial infrastructure investments |
| 2024 | 6.0% | Increasing industrial infrastructure investments |
| 2025 | 5.9% | Growing urbanization and commercial development |
| 2026 | 6.2% | Rapid growth in telecom and data center sectors |
| 2027 | 6.0% | Rising electricity demand across industries |
| 2028 | 6.0% | Expansion of manufacturing activities |
| 2029 | 6.0% | Expansion of transportation and logistics networks |
| 2030 | 6.2% | Increasing industrial infrastructure investments |
| 2031 | 6.1% | Rising electricity demand across industries |
| 2032 | 5.9% | Rapid growth in telecom and data center sectors |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In Cambodia, the biobanking sector is gaining traction as healthcare providers and researchers recognize the vital role of biological sample management in advancing medical research. A significant uptick in collaborations between local research institutions and international biobanks is fostering innovation and knowledge exchange, which is essential for local researchers.
Additionally, the rising prevalence of chronic diseases is driving demand for biobanking services. This trend signals a growing understanding of the importance of biobanks in not only supporting drug discovery but also in contributing to public health initiatives aimed at improving health outcomes across the population.
Several restraints currently hinder the growth of the Cambodia biobanking market. A significant issue is the lack of standardized regulations that govern biobanking practices, which results in variations in sample handling and quality control measures. Furthermore, limited funding and insufficient resources restrict the establishment of modern biobanks equipped with advanced technology. Public awareness regarding the importance of biobanking is still low, presenting a challenge in garnering support for its initiatives. Addressing these restraints will require collective efforts among government agencies, healthcare sectors, and research organizations to create a robust biobanking ecosystem.
The Cambodia biobanking market is witnessing several key trends, including a heightened emphasis on personalized medicine, which necessitates access to high-quality biological samples. There's also an increasing collaboration between biobanks and academic institutions, promoting data sharing and expediting scientific research. Additionally, the integration of technology in biobanking processes is evolving, with advancements in sample storage, processing, and data management solutions improving operational efficiencies.
Investors can find numerous opportunities within the Cambodia biobanking market, particularly as the country enhances its healthcare research capabilities. Developing biobanks aligned with international standards can facilitate partnerships with pharmaceutical companies, leading to shared advancements in drug discovery and genetic research. The rising occurrence of chronic diseases and government initiatives aimed at bolstering healthcare infrastructure further reinforce the potential for biobanking investments in Cambodia, promising long-term benefits for stakeholders.
While Cambodia has not yet rolled out specific policies tailored exclusively to biobanking, there are established regulations overseeing the ethical collection, storage, and use of biological samples. The Ministry of Health plays a crucial role in regulating these practices, ensuring that ethical approvals are required for sample collection. These existing frameworks lay a foundation for responsible biobanking management while simultaneously addressing privacy and confidentiality concerns related to individual biological samples.
Looking ahead to 2026-2032, the Cambodia biobanking market is poised for significant evolution, driven by increasing awareness of personalized healthcare. The demand for advanced diagnostic and therapeutic options is expected to rise, creating a robust need for high-quality biological samples for research and development. Government efforts to enhance healthcare infrastructure, along with partnerships with international biobanking organizations, are likely to spur further growth. However, attention to regulatory standardization and infrastructure improvements will be critical to fully unlock the market's potential.
Recent developments in the Cambodia biobanking market have highlighted a stronger focus on collaborative initiatives with international organizations. There has been an uptick in workshops and training programs aimed at enhancing the skills of healthcare professionals regarding biobanking practices. Additionally, the establishment of new biobanking facilities in key urban centers is underway, paving the way for improved sample management and operational efficiencies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cambodia Biobanking Market Overview |
3.1 Cambodia Country Macro Economic Indicators |
3.2 Cambodia Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 Cambodia Biobanking Market - Industry Life Cycle |
3.4 Cambodia Biobanking Market - Porter's Five Forces |
3.5 Cambodia Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Cambodia Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Cambodia Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 Cambodia Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cambodia Biobanking Market Trends |
6 Cambodia Biobanking Market, By Types |
6.1 Cambodia Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cambodia Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Cambodia Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 Cambodia Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 Cambodia Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 Cambodia Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 Cambodia Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Cambodia Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 Cambodia Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 Cambodia Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 Cambodia Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Cambodia Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 Cambodia Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 Cambodia Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 Cambodia Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 Cambodia Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 Cambodia Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 Cambodia Biobanking Market Import-Export Trade Statistics |
7.1 Cambodia Biobanking Market Export to Major Countries |
7.2 Cambodia Biobanking Market Imports from Major Countries |
8 Cambodia Biobanking Market Key Performance Indicators |
9 Cambodia Biobanking Market - Opportunity Assessment |
9.1 Cambodia Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Cambodia Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Cambodia Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 Cambodia Biobanking Market - Competitive Landscape |
10.1 Cambodia Biobanking Market Revenue Share, By Companies, 2025 |
10.2 Cambodia Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here